Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis

NCT04226170 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class

Stopped lack of enrollment

Conditions

Interventions

Sponsor

DAS-MG, Inc